tm logo
AXCELLA
Live/Registered
REGISTERED

on 14 Sep 2021

Last Applicant/ Owned by

Serial Number

87062052 filed on 06th Jun 2016

Registration Number

6486428 registered on 14th Sep 2021

in the Principal Register

Correspondent Address

Christina M. Licursi, Esq.

WOLF GREENFIELD & SACKS PC

600 ATLANTIC AVENUE

Boston, MA 02210-2206

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

AXCELLA

Dietary supplements for human and animal use; dietary supplements for restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastroRead More

Classification Information


Class [005]
Pharmaceutical Products


Dietary supplements for human and animal use; dietary supplements for restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids, and small molecules being a featured component of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, and joints; nutraceuticals for treating or restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints; dietary and nutritional supplements


First Use Date in General

19th Jul 2021

First Use Date in Commerce

19th Jul 2021

Mark Details


Serial Number

No 87062052

Mark Type

No Service/Collective Mark

Attorney Docket Number

No A119620000US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Jan 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15th Sep 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
14th Sep 2021REGISTERED-PRINCIPAL REGISTER
10th Aug 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09th Aug 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02th Aug 2021STATEMENT OF USE PROCESSING COMPLETE
27th Jul 2021TEAS STATEMENT OF USE RECEIVED
27th Jul 2021USE AMENDMENT FILED
23rd Feb 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
23rd Feb 2021CORRECTED NOA E-MAILED